wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q36930207-45439C66-8892-4188-8BB8-AE4EC323DD72
Q36930207-45439C66-8892-4188-8BB8-AE4EC323DD72
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36930207-45439C66-8892-4188-8BB8-AE4EC323DD72
PCSK9 inhibition-mediated reduction in Lp(a) with evolocumab: an analysis of 10 clinical trials and the LDL receptor's role.
P2860
Q36930207-45439C66-8892-4188-8BB8-AE4EC323DD72
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36930207-45439C66-8892-4188-8BB8-AE4EC323DD72
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
c37b00ba6c03550e069211601b86fdc7d1392159
P2860
Efficacy and safety of longer-term administration of evolocumab (AMG 145) in patients with hypercholesterolemia: 52-week results from the Open-Label Study of Long-Term Evaluation Against LDL-C (OSLER) randomized trial.